第 26 回日本認知症学会学術集会プログラム会長
東京都老人総合研究所

本間昭

認知症介入研究グループ

開催日：平成 19 年 10 月 17 日（水）～10 月 18 日（木）会場：大阪国際会議場(Grand Cube Osaka)

本年度学術集会は第 13 回国際老年精神医学会 IPA との合同開催となっております．口頭・ポスター発表の形式等は IPA と共通ですので，下記を参考にご発表のご用意をお願い申し上げます．
日程一覧：
発表形式：

http://www.congre.co.jp/ipa2007/prog_glance.html
http://www.congre.co.jp/ipa2007/free_oral.html

第 26 回日本認知症学会学術集会事務局
東京都老人総合研究所 認知症介入研究グループ内〒173-0015 東京都板橋区栄町 35-2
Phone: (03)3964-3241 x3104 / FAX: (03)3579-4776
Email: demenz1@tmig.or.jp
大阪国際会議場〒530-0005 大阪市北区中之島５丁目３番 51 号
Phone：(06)4803-5555(代) / FAX：(06)4803-5620
http://www.gco.co.jp
第 13 回国際老年精神医学会 (IPA 2007 Osaka Silver Congress)
http://www.ipa-online.org

第 26 回認知症学会参加者へのお知らせ
１．

第 26 回日本認知症学会は 10 月 17 日と 18 日の 2 日間にわたって大阪国際会議場(Grand Cube Osaka)の 10 階 Hall C (1003)で認知症学会の３つのシンポジウムが、3階でポスター発表が開催されますが、国際老年精神医学会と合同での開催です。従って、認知症学会の当日の参加登録は国際老年精神医学会(IPA 2007 Osaka Silver
Congress)への参加登録となります。国際老年精神医学会の登録受付で登録をお願いします。
２．

抄録集は学会機関誌 Dementia 第 21 巻第 2 号に掲載されます。非会員は学会場でお買い求めください（1 冊 3,000 円）。認知症学会のポスター発表の抄録は IPA の抄録集(International Psychogeriatrics の増刊号としてコングレスバッグに含まれます)に掲載されていますが、認知症学会のシンポジウムの抄録は IPA の抄録集には掲載されていませんのでご注意ください。
３．

演者へのお知らせポスター発表を含むすべての発表は IPA の発表方法に従います。
認知症学会のポスター発表は 10 月 17 日と 18 日の両日にわたって行われます。2 日間
貼りっぱなしとなります。Poster viewing は 10:10-10:45 と 15:45-16:30 の午前と午後それぞれ 1 回ずつの break の時間に設定されています。従って、ポスターは遅くとも 10 月 17 日の午前 10:10 までには張り出してください。発表時間や座長は指定しておりません。

４．

シンポジウムの座長の先生方へ打ち合わせが必要な場合は Conference room 501（認知症学会本部）をお使いください。

５．

総会は 10 月 18 日

14:00-15:00 に Room 1009 で開催されます。ぜひご参加ください。
６．

各種委員会は下記の通り開催されます。

10 月 16 日
10:00-11:00 基礎研究推進に関する委員会 (Rm805)
11:00-12:00 企画委員会 (Rm805)
12:00-15:00 専門医認定制度委員会 昼食付き (Rm805)
15:00-16:00 機関誌編集委員会 (Rm805)
16:00-18:00 理事会 (Rm805)

夕食は Gala Dinner があるため用意しておりません。

10 月 17 日
12:30-14:00 評議員会 (Rm1009)
10 月 18 日
12:30-13:45 学会奨励賞委員会（昼食含） (Rm501)

SYMPOSIUM 1: OLIGOMER ABETA IS THE NEW CULPRIT OR THERAPEUTICS?
8:40-10:10 am, October 17, Hall C (1003)
Chair: Hiroshi Mori (Osaka City University)
1. Takami Tomiyama (Osaka City University)
Oligomer Aβin animal models and human patients
2. Katsuhiko Yanagisawa (National Institute for Longevity Sciences)
A ganglioside-induced toxic soluble Aβ assembly
3. William L. Klein (Northwestern U.)
Why Alzheimer’s is a disease of memory: The attack on synapses by Aβ oligomers (ADDLs)
SYMPOSIUM 2: PROGRANULIN AND TDP-43
16:30-18:00 pm, OCTOBER 17, Hall C (1003)
Chairs: Takeshi Iwatsubo (Tokyo University)
Masato Hasegawa (Tokyo Institute of Psychiatry)
1. Mike Hutton (Department of Neuroscience, Mayo Clinic College of Medicine, USA)The role of progranulin (PGRN) in neurodegenerative diseases
2.

Ian R.A. Mackenzie (Department of Pathology, University of British Columbia, Canada)

The Clinical and Neuropathological Phenotype of FTD with Progranulin Mutations.
3.

Manuela Neumann (Center for Neuropathology and Prion Research, Ludwig Maximilians

University Munich, Germany)
Neuropathological spectrum of familial and sporadic TDP-43 proteinopathies.
4.

Tetsuaki Arai (Department of Psychogeriatrics, Tokyo Institute of Psychiatry, Japan)

Accumulation of phosphorylated TDP-43 in neurodegenerative disorders.

シンポジウム３：認知症診療と専門医

8:40-10:10, am, October 18, Hall C (1003)

座長：本間昭（東京都老人総合研究所）
1. 井原康夫（同志社大生命医科学部準備室）：専門医制度に関する概説
2. 中島健二（鳥取大神経内科）：日本認知症学会専門医制度設立に関する経緯
3. 藤本直規（藤本クリニック）：臨床現場からの専門医に対する期待
4. 佐々木健（厚生労働省老健局計画課認知症・虐待防止対策推進室認知症対策専門官）日本認知症学会専門医制度に期待すること

Alzheimer's DiseaseP2-060Involvement of the prostaglandin E2 receptors, EP2 and EP4, in the production ofamyloid-β peptides both in vitro and in vivo
Graduate School of Medical and Pharmaceutical Sciences, Kumamoto University,
Kumamoto, Japan
Tatsuya HoshinoP2-061

Angiotensin-converting enzyme converts Aβ1-42 to Aβ1-40 and its inhibition
enhances brain Aβ deposition
Department of Alzheimer's Disease Research, National Institute for Longevity Sciences,
NCGG, Obu, Japan
Kun Zou

P2-062ATP-binding cassette transporter G4 is highly expressed in Alzheimer brain.
Department of Neurology and Healthcare, Fukuoka University Hospital
Yoshinari UeharaP2-063

Suppression of APP metabolism by DHHC family proteins
Laboratory of Neuroscience, Graduate School of Pharmaceutical Sciences, Hokkaido
University, Sapporo, Japan
Chie Mizumaru

P2-064

Tissue analysis of growth hormone (GH) and α-melanocyte-stimulating hormone(α-MSH) in pituitaries of Alzheimer's patients (AD)Choju Medical Institute, Fukushimura Hospital, Toyohashi, Japan
Hiroyasu Akatsu

P2-065Specific binding of Aβ42 mimic peptides to prefibrillar soluble oligomer resulting in
the inhibition of Aβ42-fibrillation
Department of Bioengineering, Faculty of Engineering, Kagoshima University, Kagoshima,
Japan
Koichi Tanaka

P2-066Amyloid β N-terminal-end specific monoclonal antibody 82E1 reduced β-amyloid
toxicity in culture cells and cerebral amyloidosis in an Alzheimer mouse model.
Immuno-Biological Laboratories Co., Ltd., Gunma, Japan
Yuko Horikoshi-Sakuraba

P2-067

Expression of reticulon 3 in Alzheimer's disease brain
Natonal Insitute of Neuroscience, NCNP, Tokyo, Japan
Wataru Araki

P2-0684 cases of clinically diagnosed as Alzheimer's disease without accumulation ofamyloid in the brain revealed by PIB-PET.
Department of Physiology, Osaka City University Graduate School of Medicine,
Suzuka AtakaP2-069

Familial Danish dementia: Co-existence of Danish and Alzheimer amyloid subunits(ADan and Aβ) in the absence of compact plaques
Department of Neurology, University of Tsukuba, Tsukuba, Japan
Yasushi Tomidokoro

P2-070Application of brief-neuropsychological scale to patients with Alzheimer's disease inearly stage.
Department of Neuropsychiatry, Graduate School of Medicine and Pharmaceutical
Sciences, University of Toyama, Toyama, Japan
Kanade Kato

P2-071

Peripheral ethanolamine plasmalogen deficiency in SDAT: cause or effect?
Phenomenome Discoveries Inc., Saskatoon, SK, Canada
Yasuyo Yamazaki

P2-072How does the people with severe dementia engage objects in daily life ? - Pilot study
Department of Health Sciences, Faculty of Medicine, University of Kyoto, Kyoto, Japan
Haruna Shirai

P2-073

Nutritional support for the patient of frontotemporal dementia(FTD): a case report
Okehazama hospital,psychiatry,Aichi,Japan
Tatsuyo Suzuki

P2-074

Enhanced accumulation of phosphorylated α-synuclein in double transgenic miceexpressing mutant βAPP and presenilin-1
Department of Neurology, Okayama University Graduate School of Medicine, Dentistry andPharmacy, Okayama, Japan
Tomoko Kurata

P2-075

Understanding functional proteins of γ-42cleavage by proteomics analysis
Department of Post-Genomics and Diseases, Division of Psychiatry and Behavioral
Proteomics, Osaka University Graduate School of Medicine, Osaka, Japan
Takashi Oguri

P2-076

Alteration of concanavalin A binding glycoproteins in cerebrospinal fluid and serumof Alzheimer's disease patients
Division of Clinical Laboratory, Clinical Facilities, Tottori University Hospital, Tottori
University, Yonago, Japan
Yuki HashimotoP2-077

Serum glycoprotein as a new diagnostic marker for Alzheimer's disease
Department of Biological Regulation, Faculty of Medicine, Tottori University, Japan
Yuka Nakamura

P2-078Continued report of cognitive improvement on patients with Alzheimer's disease byaromatherapy.
Section of Environment and Health Science, Department of Biological Regulation, Schoolof Health Science, Faculty of Medicine, Tottori University.
Daiki Jimbo

P2-079

Beta cleavage by BACE1: New processing mechanism and BACE1 structure
RIKEN Brain Science InstituteNobuyuki Nukina

P2-080Additional factors alter ε-cleavage precision of Amyloid precursor protein in in vitro
γ-secretase assay
Psychiatry, Department of Integrated Medicine, Division of Internal Medicine, Osaka
University Graduate School of Medicine, Osaka, Japan
Kohji Mori

P2-081

An autopsy case of familial Alzheimer's disasea with a novel mutation (D678N) in the
APP gene
Department of Neurology, Institute of Neurological Sciences, Tottori University, Yonago,
Japan
Kenji Wada-Isoe

P2-082

Discontinuation of donepezil in geriatric clinic
Department of Geriatrics, Nagoya University Graduate School of Medicine
Hiroyuki Umegaki

P2-083

Living with early-stage Alzheimer's disease in Japan - perspectives from afflictedpersons
Faculty of Health Science, Tokyo Metropolitan University, Tokyo, Japan
Towako Katsuno

Behavioural and Psychological Symptoms of Dementia
P2-085

Effects of Yokukansan on BPSD and memory disturbance induced by thiamine
deficiency in mice
Tsumura Research Laboratories, Tsumura & Co.,Ibaraki,Japan
Takuji Yamaguchi

P2-086

Effect of Yokukansan on thiamine deficient-induced encephalopathy in rats: electron
microscopic analysis
TSUMURA Research Laboratories,TSUMURA & CO.,Ibaraki,Japan
Seiichi Iizuka

P2-087

Characteristics

of

Yokukansan-therapy

onaggressivenessinducedbyintraventricular Aβ-injection in mice
Tsumura Research Laboratories,Tsumura & Co.,Ibaraki,Japan
Kyoji Sekiguchi
P2-088An Asian traditional medicinal herb, Uncaria rhynchophylla, protects neuronal cells
through transcription factor regulation
Center for Asian Traditional Medicine
Katsutoshi Furukawa

P2-089

Novel therapeutic strategies useful for Alzheimer's disease from medicinal herbs
and traditional Chinese medical formula
Department of Geriatrics and Gerontology Center for Asian Traditional Medicine, Tohoku
University Graduate School of Medicine, Sendai, Japan
Hironori Fujiwara

Caregiver Issues
P2-117

The relationship between stress reaction and the attitudes towards dementia-related
aggression among Japanese formal caregivers.
Kagawa Prefectural College of Health Sciences
Hiroe Hitomi

P2-118

Effect to professional caregivers of reminiscence group therapy for the elderly withdementia
Department of Clinical Psychology, Faculty of Health and Welfare,Kawasaki University of
Medical Welfare, Kurashiki, Japan
Yumiko Okumura

Cellular and Animal Models
P2-119MR tracking of microglia transplanted in Alzheimer model rats
Molecular Neuroscience Research Center, Shiga University of Medical Science, Shiga,
Japan
Ikuo Tooyama

P2-120

LGI3 accumulates in endocytic pathway of aged monkey brains; LGI3 colocalizes
with Aβ in vivo
The Corporation for Production and Research of Laboratory Primates, Ibaraki, Japan
Sachi Okabayashi

P2-121

Effects of chronic exposure to aluminum in drinking water on an animal model oftauopathies
Department of Neuropsychiatry, Okayama University Graduate School of Medicine,
Dentistry and Pharmaceutical Sciences
Etsuko Oshima

P2-122Aβ accumulation causes postsynaptic damage in Tg2576 mice
Department of Neurology, Institute of Brain Science, Hirosaki University Graduate Schoolof Medicine, Hirosaki, Japan
Yasuhito Wakasaya

P2-123

Tau protein phosphorylation by oxidative stress via c-jun N-terminal kinase (JNK)
activation
Department of Neurology, Tokyo Medical and Dental University, Tokyo, Japan
Nobuo Sanjo

P2-124Aging attenuates dynactin-dynein interaction: down-regulation of dynein causes
accumulation of enodogenous tau and APP in human neuroblastoma cells
Laboratory of Disease Control, Tsukuba Primate Research Center, National Institue of
Biomedical Innovation, Ibaraki, Japan
Nobuyuki Kimura

P2-125

Immunohistochemical

study

on

TDP-43proteinin

amyotrophic

lateralsclerosis/parkinsonism-dementia complex of the Kii peninsula of Japan
Department of Neurology, Mie University Graduate School of Medicine, Mie, Japan
Yasumasa Kokubo
P2-126

CRB2 binds to presenilin complexes resulting in inhibited secretion of amyloid-β
peptidesMolecular Neuroscience Research Center, Shiga University of Medical Science, Otsu,
Japan
Masaki Nishimura

P2-127

Characteristics of γ-secretase activities in I213T mutant PS1 knock-in mice brain
Lab. for Alzheimer's disease, BSI, RIKEN, Saitama, Japan
Masafumi Shimojo

P2-128Different phenotypes of mouse expressing human wild and mutant P301L tau.
Laboratory for Alzheimer's Disease, Brain Science Institute, RIKEN, Saitama, Japan
Tetsuya Fukuda

P2-129The JAK2/STAT3 signaling axis regulates memory in Alzheimer's disease
Department of Anatomy, Keio University, School of Medicine
Tomohiro Chiba

P2-130

GABA-related acceleration of aging process in Alzheimer's model mouse
Lab for Alzheimer's Disease, Brain Science Institute, RIKEN, Saitama, Japan
Yuji Yoshiike

P2-131

Evaluation of the dopaminergic system in the substantia nigra in aging-accelerated
klotho mice
Department of Neurology, School of Medicine, Keio University, Tokyo, Japan
Arifumi Kosakai

P2-132Analysis of transgenic mice overexpressing mutant tau and GSK-3β
Gunma University Graduate School of Medicine, Maebashi , Gunma, Japan
Masaki Ikeda

Cognitive-Behavioral Therapy
P2-135

Hydrogen acts as a therapeutic antioxidant by selectively reducing cytotoxic oxygen
radicals in the nervous system
Department of Biochemistry and Cell Biology, Institute of Development and Aging
Sciences, Graduate School of Medicine, Nippon Medical School, Kawasaki, Japan
Ikuroh Ohsawa

P2-136

Design report: Randomized prospective learning therapy study on elderly Japanesein Osaka
Department of Psychiatry Osaka University Graduate School of Medicine, Tokyo, Japan
Takashi Morihara

Dementia with Lewy Bodies and Parkinson's Disease Dementia
P2-137

Classification of psychotic symptoms in dementia with Lewy bodies
Geriatric Neurology, Shiga Medical Center, Moriyama, Japan
Yasuhiro Nagahama

P2-138

Neurosin cleaves the NAC region of α-synuclein
Department of Neurology, Kyoto Prefectural University of Medicine , Kyoto, Japan
Takashi Kasai

Diagnostic Methods
P2-142

Value of CSF-Aβ42, total tau protein, phospholyrated tau protein in the differential
diagnosis of DLB from AD: comparison with 131I-MIBG radioactivity.
Department of Neurology and Neurobiology of Aging, Kanazawa, Japan
Moeko Shinohara

P2-143Development of DNA microarray-based high-throughput gene analysis system andits application to the molecular diagnosis of familial Alzheimer's disease
Department of Neurology, Graduate School of Medicine, The University of Tokyo, Tokyo,
Japan
Yuji Takahashi

P2-144

A Novel ELISA system for endogenous mouse Amyloid-beta 1-40 in blood.
Immuno-Biological Laboratories Co., Ltd
Nobuhiro Maruyama

P2-145

Stage Estimation of Dementia(SED):A proposal of a practical method for estimationof the stage in the course of dementia for the clinician.
Kiyohara Ryu Mental Clinic
Tatsuo Kiyohara

Fronto-Temporal Dementia
P2-154

Clinicopathological

spectrumofamyotrophic

lateralsclerosis

(ALS)

and

frontotemporal lobar degeneration (FTLD) on TDP-43 immunohistochemistry inJapanDepartment of Neuropathology, Institute for Medical Science of Aging, Aichi Medical
University, Aichi, Japan
Mari Yoshida
P2-155

FTDP-17 mutation modify the intermediate formation of tau filament
RIKEN Brain Science Institute
Sumihiro Maeda

Genetics
P2-162

Gender-related genetic loci associated with late-onset Alzheimer's disease on
chromosome 10q
Niigata University, Niigata, Japan
Akinori Miyashita

P2-163

Association study of alpha-synuclein gene polymorphism in autopsy-confirmed
degenerative dementia
Department of Geriatric Medicine, Ehime University Graduate School of Medicine, Ehime,Japan
Tetsuro MikiP2-164

Two Japanese CADASIL families exhibiting R75P mutation of Notch3 not involving
cysteine residue
Department of Molecular Neurology, Kyoto Prefectural University of Medicine, Kyoto,Japan
Toshiki Mizuno

P2-165

Driving problems arising from dementia and various cognitive impairments
Department of Geriatrics, Medicine in Growth and Aging, Program in Health andCommunity Medicine, Nagoya University Graduate School of Medicine
Naoko Kawano

Mild Cognitive Impairment
P2-166

A study of awareness of memory deficits in patients with dementias
Department of Geriatric Medicine, Tokyo Medical University, Tokyo, Japan
Haruo Hanyu

Molecular Biology
P2-201

N-cadherin enhances extracellular secretion of Aβ and modulates Aβ42/40 ratio
Department of Neurology, Kyoto University Graduate School of Medicine, Kyoto, Japan
Kengo Uemura

P2-202

Participation of Alcadein α and its proteolytic product in the axonal transport of APP
and the generation of Aβ
Laboratory of Neuroscience, Graduate School of Pharmaceutical Sciences, Hokkaido
University, Sapporo, Japan
Takanori Kawano

P2-203

Increased autophagic activity might not automatically induce amyloid β protein
production
Department of Neurology, Gunma University Graduate School of Medicine, Maebashi,
Gunma, Japan
Kouki Makioka

P2-204

Apo E isoform dependent cholesterol efflux is caused by intra-molecular domaininteraction and inter-molecular dimerization
Deprt of Alzheimer's dis Res, NILS, National Center for Geriatrics and Gerontology, Obu,Japan
Hirohisa Minagawa

P2-205Aβ amyloid accelerates accumulation of tau in neuronal processes
Department of Neurology, Institute of Brain Science, Hirosaki University Graduate Schoolof Medicine, Hirosaki, Japan
Yusuke Seino

P2-206

Quantitative change of APH-1 and presenilin in culture cells under various type ofendoplasmic reticulum (ER) stress
Department of Neurology, Tokyo Medical and Dental University, Tokyo, Japan
Nobuo Sanjo

P2-207

Dephosphorylation of Cdk5-phosphorylated FTDP-17 mutant tau
Department of Biological Sciences, Graduate School of Science, Tokyo Metropolitan
University, Tokyo, Japan
Kensuke Yotsumoto

P2-208Mutational analysis in early-onset familial Alzheimer's disease in Japanese
population revealed PSEN1 mutations, MAPT R406W mutation, and APP duplication
Department of Molecular Neuroscience, Brain Research Institute, Niigata University,
Niigata, Japan
Takeshi Ikeuchi

P2-209Assembly of two distinct dimers and higher-order oligomers from human full-lengthtau
Laboratory for Alzheimer's Disease, RIKEN Brain Science Institute, Wako-shi, Japan
Naruhiko SaharaP2-210

Phosphatidylinositol 3-kinase/AKT pathway alters the ubiquitination of theγ-secretase complex and modulates its proteasomal degradation.
Department of Neurology, Faculty of Medicine, Kyoto University, Kyoto, Japan
Nobuhisa Aoyagi

P2-211

Non-astrocytic expression of apolipoprotein E in the brain
Department of Neurology, Tokyo Metropolitan Institute for Neuroscience, Tokyo, Japan
Toshiki Uchihara

P2-212Contribution of endogenous GRKs to phosphorylation of alpha-synuclein at Ser129
in cultured cells
Department of Neurology, Hematology, Metabolism, Endocrinology and Diabetology,
Yamagata University Faculty of Medicine, Yamagata, Japan
Hiroyasu Sato

P2-213

Effectsofphosphoinisitideson

gamma-secretaseactivityindetergentsoluble/insoluble states
Neuropathology, Faculty of Medicine, The University of Tokyo, Tokyo, Japan
Satoko Osawa
P2-214The expression of mPGES-1 relevant to Alzheimer's disease pathology in mousemodel of Alzheimer's disease
Department of Clinical Pharmacology, Faculty of pharmaceutical Sciences, Fukuoka
University, Fukuoka, Japan
Masahiro Haji

Nursing
P2-215The understanding of prevention methods for dementia: a questionnaire survey forattendants at a dementia lecture
The University of Tokushima, Graduate School of Health Sciences, Department ofCommunity and Psychiatric Nursing
Toshiko Tada

Other
P2-247The Brain Bank for Aging Research Project
Department of Neuropathology, Tokyo Metropolitan Institute of Gerontology
Shigeo Murayama

P2-249

CSF orexin levels in patients with neurodegenerative diseases
Department of Neurology, Institute of Neurological Sciences, Faculty of Medicine, Tottori
University, Yonago, Japan
Kenichi Yasui

Other Dementias
P2-250

Leucine-rich α-2-glycoprotein is a potential biological marker for idiopathic normalpressure hydrocephalus .
Department of Neurosurgery,Juntendo University School of Medicine,Tokyo,Japan
Madoka Nakajima

P2-251

Prevalence of medical comorbidity in patients with dementia
Department of Geriatric Medicine,Tokyo Medical University Hospital,Tokyo,Japan
Hirofumi Sakurai

P2-252

Pathological features of the Gallyas- and Tau-positive glia in the amyotrophic lateralsclerosis and parkinsonism-dementia complex of Kii peninsula of Japan
Department of Neurology, Mie Univercity Graduate School of Medicine
Atsushi Niwa

P2-253Clinical database for dementia of the National Center for Geriatrics and Gerontology
National Center for Geriatrics and Gerontology, Obu,Japan
Yukihiko Washimi

P2-254

Proteomic analysis of microvessels of CADASIL brain
Department of Vasucular Dementia Research, National Institute for Longevity Sciences,Obu, Japan
Atsushi Watanabe

Service Delivery
P2-259Case study on a schizophrenic patient complicated with dementia -Focusing on theintervention by occupational therapist
Juridical Foundation The Institute of Clinical Psychiatry,Tokyo,Japan
Atsushi Ohata

The Role of Assistive Technologies
P2-260Preventive measures and fact finding research on senile dementia and depression
in the cold climate
Department of foreign language,Hokkaido Bunkyo University
Kiyoko Kamada

Treatments for Dementia
P2-261

Characterization of therapeutic antibody against Aβ oligomers for Alzheimers
disease
Department of Alzheimers Disease Research, National Institute for Longevity Sciences,
National Center for Geriatrics and Gerontology, Obu, Japan
Hui SunP2-262

Quantitation of amyloid β protein in cerebrospinal fluid from patients taking various
statins in comparison with control subjects
Medical Sciences for Control of Pathological Processes, the Graduate School ofComprehensive Human Sciences, University of Tsukuba
Hirotsugu Harada

P2-263

Snapshots of Amyloid-beta 1-42 conformers by human antibody-displaying phagelibrary
Department of Bioengineering, Faculty of Engineering, University of Kagoshima,
Kagoshima, Japan
Sho Takiguchi

P2-264

A new therapeutic agent for Alzheimer disease: Modulation of reactive astrocytes byarundic acid (ONO-2506) reduces amyloidogenesis in Alzheimer transgenic miceInstitute of Medical Science, Department of Pathology, Saitama Medical Center/Saitama
Medical University, Saitama, Japan
Yoshiko Nojima

P2-265A new therapeutic agent for Alzheimer disease: Arundic acid (ONO-2506) attenuates
cerebral amyloidosis and gliosis in Alzheimer transgenic miceInstitute of Medical Science, Department of Pathology, Saitama Medical Center/Saitama
Medical University, Saitama, Japan
Takashi Mori

P2-266

Inhibition of amyloid beta fibrillation and formation of soluble amyloid oligomers bymolecularchaperone
JST PRESTO/RIKEN Bioengineering lab
Masafumi Sakono

Vascular Cognitive Impairment and Vascular Dementia
P2-281

Discussion of dominant brain in vascular dementia of internal thalamic infarction comparison of two cases of various-side internal thalamic infarction Department of Internal Medicine
Tetsuo Mizuhara

Sanoigawatani Hospital, Kobe, Japan

Other (Free Communication)
FC02-01

Development of the Japanese version care planning assessment tool (J-CPAT):
reliability and validity studies
Yuai Clinic, Yuaikai, Saga, Japan
Sumiko Kanegae

Mild Cognitive Impairment (Free Communication )FC11-01

The impaired imitation of meaningless-movement in mild cognitive impairment andearly-stage Alzheimer's disease
Department of Geriatrics, Medicine in Growth and Aging, Program in Health andCommunity Medicine, Nagoya University Graduate School of Medicine.
Naoko Kawano

Symposium
S30-5

Value of analyzing deep gray matter and occipital lobe perfusion to differentiate
dementia with Lewy bodies from Alzheimer's disease
Department of Geriatric Medicine, Tokyo Medical University, Tokyo, Japan
Soichiro Shimizu

S30-8

Striatal alpha-synuclein accumulation in dementia with Lewy bodies
Department of Neurology, Juntendo University School of Medicine, Tokyo, Japan
Kimiko Obi